US Stock MarketDetailed Quotes

COCH Envoy Medical

Watchlist

2.405
+0.075+3.22%

Close May 30 16:00 ET

47.14MMarket Cap-1576P/E (TTM)

Envoy Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(FY)Dec 31, 2021

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-94.15%-5.85M

-100.50%-17.65M

-392.14%-11.71M

144.35%1.1M

-4.03M

-3.01M

-26.95%-8.81M

-2.38M

-2.48M

-6.94M

Net income from continuing operations

52.69%-6.27M

-87.83%-29.91M

57.47%-4.88M

209.93%1.47M

---13.25M

-83.55%-15.92M

---11.48M

---1.34M

---8.68M

Operating gains losses

1,184.62%1.34M

-5,362.86%-1.84M

-14,391.67%-1.72M

---231K

--0

--104K

3,400.00%35K

--12K

----

--1K

Depreciation and amortization

25.93%34K

77.33%133K

84.62%48K

31.82%29K

--29K

--27K

5.63%75K

--26K

--22K

--71K

Other non cash items

-99.67%31K

86.50%13.45M

-99.65%30K

-778.68%-4.78M

--8.8M

--9.4M

312.41%7.21M

--8.6M

---544K

--1.75M

Change In working capital

-263.77%-1.19M

-498.75%-958K

-1,485.31%-6.79M

836.56%4.71M

--390K

--726K

-95.12%-160K

--490K

---640K

---82K

-Change in receivables

316.67%25K

-536.17%-205K

-344.64%-137K

---54K

---20K

--6K

347.37%47K

--56K

--0

---19K

-Change in inventory

---140K

94.85%-10K

-193.75%-30K

109.33%14K

--6K

--0

-452.73%-194K

--32K

---150K

--55K

-Change in prepaid assets

-16.22%-43K

-2,278.95%-828K

-46.67%40K

-511.30%-703K

---128K

---37K

265.22%38K

--75K

---115K

---23K

-Change in payables and accrued expense

-219.09%-998K

-3.79%457K

-906.71%-6.62M

1,730.41%5.58M

--658K

--838K

541.89%475K

--820K

---342K

--74K

-Change in other current liabilities

59.26%-33K

29.28%-372K

90.67%-46K

-260.61%-119K

---126K

---81K

-211.24%-526K

---493K

---33K

---169K

Cash from discontinued investing activities

Operating cash flow

-94.15%-5.85M

-100.50%-17.65M

-392.14%-11.71M

144.35%1.1M

---4.03M

---3.01M

-26.95%-8.81M

---2.38M

---2.48M

---6.94M

Investing cash flow

Cash flow from continuing investing activities

-84.75%-109K

29.82%-153K

48.78%-21K

18.42%-62K

-11K

-59K

-74.40%-218K

-41K

-76K

-125K

Net PPE purchase and sale

-84.75%-109K

29.82%-153K

48.78%-21K

18.42%-62K

---11K

---59K

-74.40%-218K

---41K

---76K

---125K

Cash from discontinued investing activities

Investing cash flow

-84.75%-109K

29.82%-153K

48.78%-21K

18.42%-62K

---11K

---59K

-74.40%-218K

---41K

---76K

---125K

Financing cash flow

Cash flow from continuing financing activities

67.08%6.68M

169.96%21.85M

-144.55%-891K

408.93%15.74M

0.42%8.09M

3.09M

8.06M

Net issuance payments of debt

25.00%5M

25.00%10M

--0

0.00%3M

--3M

--4M

0.00%8M

--2M

--3M

--8M

Net common stock issuance

--1.68M

--109K

----

--0

----

Net preferred stock issuance

----

--11.74M

--0

----

--0

----

Proceeds from stock option exercised by employees

----

--0

----

58.62%92K

--0

----

--58K

Cash from discontinued financing activities

Financing cash flow

67.08%6.68M

169.96%21.85M

-144.55%-891K

408.93%15.74M

--3M

--4M

0.42%8.09M

--2M

--3.09M

--8.06M

Net cash flow

Beginning cash position

2,204.92%4.22M

-83.68%183K

2,665.19%16.84M

-5.56%68K

--1.11M

--183K

736.57%1.12M

--609K

--72K

--134K

Current changes in cash

-21.72%728K

533.73%4.04M

-2,904.76%-12.62M

3,017.66%16.77M

---1.05M

--930K

-193.38%-931K

---420K

--538K

--997K

Effect of exchange rate changes

-200.00%-1K

57.14%-3K

66.67%-2K

----

--1K

30.00%-7K

---6K

----

---10K

End cash Position

343.90%4.95M

2,204.92%4.22M

2,665.19%16.84M

--68K

--1.11M

-83.68%183K

--183K

--609K

--1.12M

Free cash flow

-93.97%-5.96M

-97.35%-17.81M

-384.67%-11.73M

140.60%1.04M

---4.05M

---3.07M

-27.79%-9.02M

---2.42M

---2.55M

---7.06M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-94.15%-5.85M	-100.50%-17.65M	-392.14%-11.71M	144.35%1.1M	-4.03M	-3.01M	-26.95%-8.81M	-2.38M	-2.48M	-6.94M
Net income from continuing operations	52.69%-6.27M	-87.83%-29.91M	57.47%-4.88M	209.93%1.47M	---13.25M	---13.25M	-83.55%-15.92M	---11.48M	---1.34M	---8.68M
Operating gains losses	1,184.62%1.34M	-5,362.86%-1.84M	-14,391.67%-1.72M	---231K	--0	--104K	3,400.00%35K	--12K	----	--1K
Depreciation and amortization	25.93%34K	77.33%133K	84.62%48K	31.82%29K	--29K	--27K	5.63%75K	--26K	--22K	--71K
Other non cash items	-99.67%31K	86.50%13.45M	-99.65%30K	-778.68%-4.78M	--8.8M	--9.4M	312.41%7.21M	--8.6M	---544K	--1.75M
Change In working capital	-263.77%-1.19M	-498.75%-958K	-1,485.31%-6.79M	836.56%4.71M	--390K	--726K	-95.12%-160K	--490K	---640K	---82K
-Change in receivables	316.67%25K	-536.17%-205K	-344.64%-137K	---54K	---20K	--6K	347.37%47K	--56K	--0	---19K
-Change in inventory	---140K	94.85%-10K	-193.75%-30K	109.33%14K	--6K	--0	-452.73%-194K	--32K	---150K	--55K
-Change in prepaid assets	-16.22%-43K	-2,278.95%-828K	-46.67%40K	-511.30%-703K	---128K	---37K	265.22%38K	--75K	---115K	---23K
-Change in payables and accrued expense	-219.09%-998K	-3.79%457K	-906.71%-6.62M	1,730.41%5.58M	--658K	--838K	541.89%475K	--820K	---342K	--74K
-Change in other current liabilities	59.26%-33K	29.28%-372K	90.67%-46K	-260.61%-119K	---126K	---81K	-211.24%-526K	---493K	---33K	---169K
Cash from discontinued investing activities
Operating cash flow	-94.15%-5.85M	-100.50%-17.65M	-392.14%-11.71M	144.35%1.1M	---4.03M	---3.01M	-26.95%-8.81M	---2.38M	---2.48M	---6.94M
Investing cash flow
Cash flow from continuing investing activities	-84.75%-109K	29.82%-153K	48.78%-21K	18.42%-62K	-11K	-59K	-74.40%-218K	-41K	-76K	-125K
Net PPE purchase and sale	-84.75%-109K	29.82%-153K	48.78%-21K	18.42%-62K	---11K	---59K	-74.40%-218K	---41K	---76K	---125K
Cash from discontinued investing activities
Investing cash flow	-84.75%-109K	29.82%-153K	48.78%-21K	18.42%-62K	---11K	---59K	-74.40%-218K	---41K	---76K	---125K
Financing cash flow
Cash flow from continuing financing activities	67.08%6.68M	169.96%21.85M	-144.55%-891K	408.93%15.74M	3M	4M	0.42%8.09M	2M	3.09M	8.06M
Net issuance payments of debt	25.00%5M	25.00%10M	--0	0.00%3M	--3M	--4M	0.00%8M	--2M	--3M	--8M
Net common stock issuance	--1.68M	--109K	----	----	----	--0	--0	----	----	----
Net preferred stock issuance	----	--11.74M	--0	----	----	----	--0	--0	----	----
Proceeds from stock option exercised by employees	----	--0	--0	----	----	----	58.62%92K	--0	----	--58K
Cash from discontinued financing activities
Financing cash flow	67.08%6.68M	169.96%21.85M	-144.55%-891K	408.93%15.74M	--3M	--4M	0.42%8.09M	--2M	--3.09M	--8.06M
Net cash flow
Beginning cash position	2,204.92%4.22M	-83.68%183K	2,665.19%16.84M	-5.56%68K	--1.11M	--183K	736.57%1.12M	--609K	--72K	--134K
Current changes in cash	-21.72%728K	533.73%4.04M	-2,904.76%-12.62M	3,017.66%16.77M	---1.05M	--930K	-193.38%-931K	---420K	--538K	--997K
Effect of exchange rate changes	-200.00%-1K	57.14%-3K	66.67%-2K	----	----	--1K	30.00%-7K	---6K	----	---10K
End cash Position	343.90%4.95M	2,204.92%4.22M	2,204.92%4.22M	2,665.19%16.84M	--68K	--1.11M	-83.68%183K	--183K	--609K	--1.12M
Free cash flow	-93.97%-5.96M	-97.35%-17.81M	-384.67%-11.73M	140.60%1.04M	---4.05M	---3.07M	-27.79%-9.02M	---2.42M	---2.55M	---7.06M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall